Catalyst Wire Dossier Catalyst Wire Dossier

Trop-2 ADC

Trop-2-targeting antibody-drug conjugate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trop-2 ADC, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Trop-2 ADC in Breast Cancer Patients With Brain Metastases: A Real-World Study

See pricing